Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease

被引：5

作者：

Banerjee, Tanima ^{[1
]}

Mukherjee, Somaditya ^{[1
]}

Biswas, Monodeep ^{[2
]}

Dutta, Santanu ^{[3
]}

Chatterjee, Shelly ^{[1
]}

Ghosh, Sudip ^{[1
]}

Pattari, Sanjib ^{[4
]}

Nanda, Navin C. ^{[5
]}

Bandyopadhyay, Arun ^{[1
]}

机构：

[1] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata 700032, India

[2] Temple Univ, Mercy Hosp, Philadelphia, PA 19122 USA

[3] SSKM Hosp, Postgrad Inst Med Educ & Res, Dept Cardiothorac & Vasc Surg, Kolkata, India

[4] Rabindra Nath Tagore Inst Cardiac Sci, Dept Pathol, Kolkata, India

[5] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2012年 / 156卷 / 01期

关键词：

Mitral valve; Biomarker; Collagen; Fibrosis; Heart; MYOCARDIAL FIBROSIS; TURNOVER;

D O I：

10.1016/j.ijcard.2012.01.026

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：117 / 119

页数：3

共 50 条

[21] Serum levels of carboxy-terminal propeptide of Type 1 procollagen do not reflect the severity of nonalcoholic steatohepatitis
Okan, Abdullah
Tankurt, Ethem
Sabuncuoglu, Defne
Sonsuz, Abdullah
Guener, Guel
Sagol, Oezgul
Oezbay, Guelsen
Goenen, Oemuer
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2007, 27 (01): : 27 - 31
[22] Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure
Stienen, Susan
Ferreira, Joao Pedro
Pitt, Bertram
Cleland, John G.
Pellicori, Pierpaolo
Girerd, Nicolas
Rossignol, Patrick
Zannad, Faiez
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 901 - 903
[23] Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease
Miyakawa, M
Tsushima, T
Demura, H
ENDOCRINE JOURNAL, 1996, 43 (06) : 701 - 708
[24] Serum carboxy-terminal propeptide of human type I procollagen (PIP) is a marker of myocardial fibrosis in patients with early type 2 diabetes mellitus
Ihm, S. -H.
Youn, H. -J.
Chang, K. -Y.
Park, C. -S.
Seung, K. -B.
Kim, J. -H.
Hong, S. -J.
Choi, K. -B.
EUROPEAN HEART JOURNAL, 2005, 26 : 490 - 490
[25] Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with Type 2 diabetes mellitus
Inukai, T
Fujiwara, Y
Tayama, K
Aso, Y
Takemura, Y
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 48 (01) : 23 - 28
[26] PROCOLLAGEN TYPE I CARBOXY-TERMINAL PROPEPTIDE IS ASSOCIATED WITH BLOOD PRESSURE, CARDIAC HYPERTROPHY AND DYSFUNCTION, AND PREDICT CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS
Nam, Yunju
Kang, Eunjin
Yoon, Hye Eun
Shin, Seok Joon
JOURNAL OF HYPERTENSION, 2016, 34 : E116 - E116
[27] ISOLATION AND PARTIAL CHARACTERIZATION OF THE CARBOXY-TERMINAL PROPEPTIDE OF TYPE-II PROCOLLAGEN FROM CHICK-EMBRYOS
CURRAN, S
PROCKOP, DJ
BIOCHEMISTRY, 1984, 23 (04) : 741 - 746
[28] Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
Yang, Chengzhi
Qiao, Shubin
Song, Yunhu
Liu, Yun
Tang, Yajie
Deng, Long
Yuan, Jiansong
Hu, Fenghuan
Yang, Weixian
CARDIOVASCULAR PATHOLOGY, 2019, 43
[29] EFFECTS OF A COMBINED ESTROGEN-GESTAGEN REGIMEN ON SERUM LEVELS OF THE CARBOXY-TERMINAL PROPEPTIDE OF HUMAN TYPE-I PROCOLLAGEN IN OSTEOPOROSIS
HASLING, C
ERIKSEN, EF
MELKKO, J
RISTELI, L
CHARLES, P
MOSEKILDE, L
RISTELI, J
JOURNAL OF BONE AND MINERAL RESEARCH, 1991, 6 (12) : 1295 - 1300
[30] PROCOLLAGEN TYPE I CARBOXY-TERMINAL PROPEPTIDE IS ASSOCIATED WITH BLOOD PRESSURE, CARDIAC HYPERTROPHY AND DYSFUNCTION, AND PREDICT CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS
Kim, Y. O.
Choi, B. M.
Shin, S. J.
CARDIOLOGY, 2016, 134 : 249 - 249

← 1 2 3 4 5 →